ERNA vs TROW · P/E 0.0, rev $582.0K vs P/E 12, rev $7.09B
Eterna Therapeutics Inc (ERNA) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported TROW revenue for 2024-12-31 was $7.09B. Net income was $2.14B. Revenue was up 9.8% from 2023-12-31 to 2024-12-31. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the ERNA and TROW stock pages for the full models.
Not investment advice.